Engineer - SecOps - Identity PAM & Encryption Services at Eli Lilly and Company

Cork, County Cork, Ireland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Eager to make a significant impact in the cybersecurity field with innovative ideas and daring solutions
Growth mindset and customer-focused approach
Ability to participate in a structured on-call rotation covering weekends and country holidays (Friday 7pm – Sunday 7pm local time, two weekend shifts every 4–6 weeks)
Technical expertise in supporting 24/7 identity privileged access management (PAM) and encryption platforms and services
Capability to handle day-to-day operations, incident management, change management, and problem resolution related to Identity and Access Management (IAM)
Ability to collaborate with cross-functional teams to maintain compliance, address risks, and ensure secure, appropriate, and timely access to enterprise resources

Responsibilities

Deliver secure, appropriate, and timely access to enterprise resources
Support capabilities to achieve and sustain the Identity and Access Management (IAM) strategy
Perform day-to-day operations for IAM, PAM, and encryption platforms and services
Manage incidents, changes, and problem resolution related to IAM
Participate in on-call rotation to resolve priority IAM requests outside standard working hours for 24/7 operational resilience
Collaborate with cross-functional teams to maintain compliance and address risks

Skills

PAM

Encryption

Identity Management

SecOps

Cybersecurity

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free